10 Apr 2019

Notice for Yellow Fever Vaccination Centres: Leaving the EU – yellow fever vaccine supply

NaTHNaC receives reassurance that contingencies for continuous yellow fever vaccine supply to the UK are robust and sustainable in the event of a ‘no deal’ EU Exit Notice for Yellow Fever Vaccination Centres: Leaving the EU – yellow fever vaccine supply

On behalf of Yellow Fever Vaccination Centres (YFVC) in England, Wales and Northern Ireland, NaTHNaC has been working closely with Sanofi Pasteur who manufacture, pack and supply yellow fever vaccine in France for the UK market. Sanofi Pasteur advises that their contingency plan for a ‘no deal’ EU Exit includes increasing yellow fever vaccine stock levels and securing alternative and robust supply lines into the UK.

Local stockpiling is unnecessary and YFVC should continue to order YF vaccine as usual.

Further updates will be provided when available.

Resources

MHRA issue a reminder for healthcare professionals administering yellow fever vaccine

This alert highlights two reports of fatal adverse reactions to yellow fever vaccine and the importance of a detailed risk assessment before vaccination Read more

Country Focus: Pakistan

Pre-travel advice for those going to Pakistan Read more

New interactive malaria maps

Searchable malaria maps have been loaded on to the country pages for Bangladesh, Ethiopia, Pakistan and Tanzania Read more

Travellers’ diarrhoea: factsheet update

Advice on the use of antibiotics for standby treatment of diarrhoea has been updated Read more
Back to Top

VIEW FULL INDEX